标题
Apoptosis Deregulation and the Development of Cancer Multi-Drug Resistance
作者
关键词
-
出版物
Cancers
Volume 13, Issue 17, Pages 4363
出版商
MDPI AG
发表日期
2021-08-30
DOI
10.3390/cancers13174363
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Addressing resistance to immune checkpoint inhibitor therapy – an urgent unmet need
- (2021) Siwen Hu-Lieskovan et al. Future Oncology
- Targeting epigenetic regulatory machinery to overcome cancer therapy resistance
- (2021) Lei Guo et al. SEMINARS IN CANCER BIOLOGY
- Exosomal long non-coding RNA LINC00662 promotes non-small cell lung cancer progression by miR-320d/E2F1 axis
- (2021) Xin Lv et al. Aging-US
- Exosomes secreted from cancer-associated fibroblasts elicit anti-pyrimidine drug resistance through modulation of its transporter in malignant lymphoma
- (2021) Shunsuke Kunou et al. ONCOGENE
- Role of cancer‑associated fibroblasts in the resistance to antitumor therapy, and their potential therapeutic mechanisms in non‑small cell lung cancer (Review)
- (2021) Congcong Chen et al. Oncology Letters
- Therapeutic Targeting of the Tumor Microenvironment
- (2021) Leire Bejarano et al. Cancer Discovery
- miRNAs and lncRNAs as Novel Therapeutic Targets to Improve Cancer Immunotherapy
- (2021) Maria Teresa Di Martino et al. Cancers
- The Role of Cancer-Associated Fibroblasts in Tumor Progression
- (2021) Rushikesh S. Joshi et al. Cancers
- The Role of Tumor Microenvironment in Cancer Metastasis: Molecular Mechanisms and Therapeutic Opportunities
- (2021) Christiana M. Neophytou et al. Cancers
- Exosomal lncRNA UCA1 modulates cervical cancer stem cell self-renewal and differentiation through microRNA-122-5p/SOX2 axis
- (2021) Zhihui Gao et al. Journal of Translational Medicine
- Aspects of the Tumor Microenvironment Involved in Immune Resistance and Drug Resistance
- (2021) Khalil Khalaf et al. Frontiers in Immunology
- Cancer statistics, 2020
- (2020) Rebecca L. Siegel et al. CA-A CANCER JOURNAL FOR CLINICIANS
- A conserved intratumoral regulatory T cell signature identifies 4-1BB as a pan-cancer target
- (2020) Zachary T. Freeman et al. JOURNAL OF CLINICAL INVESTIGATION
- Venetoclax, a BCL-2 Inhibitor, Enhances the Efficacy of Chemotherapeutic Agents in Wild-Type ABCG2-Overexpression-Mediated MDR Cancer Cells
- (2020) Jing-Quan Wang et al. Cancers
- Fibroblast‑derived exosomal microRNA‑369 potentiates migration and invasion of lung squamous cell carcinoma�cells via NF1‑mediated MAPK signaling pathway
- (2020) Liping Guo et al. INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE
- Mechanisms of Multidrug Resistance in Cancer Chemotherapy
- (2020) Karol Bukowski et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Long non-coding RNAs regulate drug resistance in cancer
- (2020) Kaisheng Liu et al. Molecular Cancer
- Epigenetic regulation in human cancer: the potential role of epi-drug in cancer therapy
- (2020) Yuanjun Lu et al. Molecular Cancer
- A dual PI3 kinase/mTOR inhibitor BEZ235 reverses doxorubicin resistance in ABCB1 overexpressing ovarian and pancreatic cancer cell lines
- (2020) David E. Durrant et al. BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS
- Role of FOXO Transcription Factors in Cancer Metabolism and Angiogenesis
- (2020) Mohd Farhan et al. Cells
- The Role of Tumor-Associated Myeloid Cells in Modulating Cancer Therapy
- (2020) Christiana M. Neophytou et al. Frontiers in Oncology
- CD137 agonist induces gastric cancer cell apoptosis by enhancing the functions of CD8+ T cells via NF-κB signaling
- (2020) Ben-Shun Hu et al. Cancer Cell International
- PI3K/AKT pathway as a key link modulates the multidrug resistance of cancers
- (2020) Rui Liu et al. Cell Death & Disease
- Carcinoma-Associated Fibroblasts Promote Growth of Sox2-Expressing Breast Cancer Cells
- (2020) Angela Dittmer et al. Cancers
- Propagation and Maintenance of Cancer Stem Cells: A Major Influence of the Long Non-Coding RNA H19
- (2020) Clément Lecerf et al. Cells
- Loss of microRNA-30e induced by extracellular vesicles from cancer-associated fibroblasts promotes breast cancer progression by binding to CTHRC1
- (2020) Chunfang Xi et al. EXPERIMENTAL AND MOLECULAR PATHOLOGY
- The PROTAC technology in drug development
- (2019) Yutian Zou et al. CELL BIOCHEMISTRY AND FUNCTION
- Targeting epigenetic modifications in cancer therapy: erasing the roadmap to cancer
- (2019) Helai P. Mohammad et al. NATURE MEDICINE
- Cancer-associated fibroblasts produce Netrin-1 to control cancer cell plasticity
- (2019) Pei-Ju Sung et al. CANCER RESEARCH
- Aggressive variants of prostate cancer – Are we ready to apply specific treatment right now?
- (2019) Igor Tsaur et al. CANCER TREATMENT REVIEWS
- Targeting interleukin-6 as a strategy to overcome stroma-induced resistance to chemotherapy in gastric cancer
- (2019) In-Hye Ham et al. Molecular Cancer
- Role of the PI3K/AKT/mTOR signaling pathway in ovarian cancer: Biological and therapeutic significance
- (2019) Meran Keshawa Ediriweera et al. SEMINARS IN CANCER BIOLOGY
- The PAX6-ZEB2 axis promotes metastasis and cisplatin resistance in non-small cell lung cancer through PI3K/AKT signaling
- (2019) Dong-ming Wu et al. Cell Death & Disease
- Collateral Sensitivity of Parthenolide via NF-κB and HIF-α Inhibition and Epigenetic Changes in Drug-Resistant Cancer Cell Lines
- (2019) Mona Dawood et al. Frontiers in Pharmacology
- Progression-Related Loss of Stromal Caveolin 1 Levels Mediates Radiation Resistance in Prostate Carcinoma via the Apoptosis Inhibitor TRIAP1
- (2019) Julia Ketteler et al. Journal of Clinical Medicine
- Targeting the phosphoinositide 3-kinase/AKT pathways by small molecules and natural compounds as a therapeutic approach for breast cancer cells
- (2019) Amin Soltani et al. MOLECULAR BIOLOGY REPORTS
- The multi-factorial nature of clinical multidrug resistance in cancer
- (2019) Yehuda G. Assaraf et al. DRUG RESISTANCE UPDATES
- Cancer therapeutics using survivin BIRC5 as a target: what can we do after over two decades of study?
- (2019) Fengzhi Li et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Combining epigenetic drugs with other therapies for solid tumours — past lessons and future promise
- (2019) Daphné Morel et al. Nature Reviews Clinical Oncology
- Targeting AKT for cancer therapy
- (2019) Maryam Shariati et al. EXPERT OPINION ON INVESTIGATIONAL DRUGS
- The Antitumor Effect of Lipophilic Bisphosphonate BPH1222 in Melanoma Models: The Role of the PI3K/Akt Pathway and the Small G Protein Rheb
- (2019) Rittler et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Role of regulatory miRNAs of the PI3K/AKT/mTOR signaling in the pathogenesis of hepatocellular carcinoma
- (2019) Farzad Rahmani et al. JOURNAL OF CELLULAR PHYSIOLOGY
- The great escape: tumour cell plasticity in resistance to targeted therapy
- (2019) Soufiane Boumahdi et al. NATURE REVIEWS DRUG DISCOVERY
- Combination anti–CTLA-4 plus anti–PD-1 checkpoint blockade utilizes cellular mechanisms partially distinct from monotherapies
- (2019) Spencer C. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Targeting oncogenic SOX2 in human cancer cells: therapeutic application
- (2019) Shizhen Zhang et al. Protein & Cell
- microRNA-181d-5p-containing exosomes derived from cancer-associated fibroblasts promote epithelial-mesenchymal transition by regulating CDX2/HOXA5 in breast cancer
- (2019) Hongbin Wang et al. Molecular Therapy-Nucleic Acids
- The timeline of epigenetic drug discovery: from reality to dreams
- (2019) A. Ganesan et al. Clinical Epigenetics
- BRD4 Inhibition Is Synthetic Lethal with PARP Inhibitors through the Induction of Homologous Recombination Deficiency
- (2018) Chaoyang Sun et al. CANCER CELL
- Activated gastric cancer-associated fibroblasts contribute to the malignant phenotype and 5-FU resistance via paracrine action in gastric cancer
- (2018) Yongchen Ma et al. Cancer Cell International
- The Critical Role of PTEN/PI3K/AKT Signaling Pathway in Shikonin-Induced Apoptosis and Proliferation Inhibition of Chronic Myeloid Leukemia
- (2018) Yu Chen et al. CELLULAR PHYSIOLOGY AND BIOCHEMISTRY
- Integrative Kinome Profiling Identifies mTORC1/2 Inhibition as Treatment Strategy in Ovarian Clear Cell Carcinoma
- (2018) Joseph J. Caumanns et al. CLINICAL CANCER RESEARCH
- Role of miRNAs in cell signaling of cancer associated fibroblasts
- (2018) A.K. Eichelmann et al. INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY
- Fisetin mediated apoptotic cell death in parental and Oxaliplatin/irinotecan resistant colorectal cancer cells in vitro and in vivo
- (2018) Long-Bin Jeng et al. JOURNAL OF CELLULAR PHYSIOLOGY
- Carcinoma-associated fibroblasts promote the stemness and chemoresistance of colorectal cancer by transferring exosomal lncRNA H19
- (2018) Jing Ren et al. Theranostics
- Androgen receptor expression reduces stemness characteristics of prostate cancer cells (PC3) by repression of CD44 and SOX2
- (2018) Deepa Srinivasan et al. JOURNAL OF CELLULAR BIOCHEMISTRY
- The role of cellular reactive oxygen species in cancer chemotherapy
- (2018) Haotian Yang et al. JOURNAL OF EXPERIMENTAL & CLINICAL CANCER RESEARCH
- Tumor-related interleukins: old validated targets for new anti-cancer drug development
- (2017) Sarra Setrerrahmane et al. Molecular Cancer
- The cancer epigenome: Concepts, challenges, and therapeutic opportunities
- (2017) Mark A. Dawson SCIENCE
- Netrin-1 in cancer: Potential biomarker and therapeutic target?
- (2017) Umut Kefeli et al. TUMOR BIOLOGY
- Schiff base derived from thiosemicarbazone and anthracene showed high potential in overcoming multidrug resistance in vitro with low drug resistance index
- (2017) Jie Bai et al. Drug Design Development and Therapy
- IL-6 secreted by cancer-associated fibroblasts promotes epithelial-mesenchymal transition and metastasis of gastric cancer via JAK2/STAT3 signaling pathway
- (2017) Xiongyan Wu et al. Oncotarget
- Epigenetic strategies to reverse drug resistance in heterogeneous multiple myeloma
- (2017) Mark E. Issa et al. Clinical Epigenetics
- Tumor cell-intrinsic phenotypic plasticity facilitates adaptive cellular reprogramming driving acquired drug resistance
- (2017) Heinz Hammerlindl et al. Journal of Cell Communication and Signaling
- Midkine derived from cancer-associated fibroblasts promotes cisplatin-resistance via up-regulation of the expression of lncRNA ANRIL in tumour cells
- (2017) Dongya Zhang et al. Scientific Reports
- The anti-fibrotic agent pirfenidone synergizes with cisplatin in killing tumor cells and cancer-associated fibroblasts
- (2016) Melanie Mediavilla-Varela et al. BMC CANCER
- Cisplatin-induced CCL5 secretion from CAFs promotes cisplatin-resistance in ovarian cancer via regulation of the STAT3 and PI3K/Akt signaling pathways
- (2016) BO ZHOU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- An analysis of the role of follicular lymphoma-associated fibroblasts to promote tumor cell viability following drug-induced apoptosis
- (2016) Annette M. Staiger et al. LEUKEMIA & LYMPHOMA
- Generation of Soluble Interleukin-11 and Interleukin-6 Receptors: A Crucial Function for Proteases during Inflammation
- (2016) Juliane Lokau et al. MEDIATORS OF INFLAMMATION
- BCL2 Inhibitors as Anticancer Drugs: A Plethora of Misleading BH3 Mimetics
- (2016) R. S. Soderquist et al. MOLECULAR CANCER THERAPEUTICS
- The Therapeutic Potential of Targeting the HGF/cMET Axis in Ovarian Cancer
- (2016) Kim Moran-Jones Molecular Diagnosis & Therapy
- Osthole shows the potential to overcome P-glycoprotein-mediated multidrug resistance in human myelogenous leukemia K562/ADM cells by inhibiting the PI3K/Akt signaling pathway
- (2016) HONG WANG et al. ONCOLOGY REPORTS
- Non-coding RNAs in Development and Disease: Background, Mechanisms, and Therapeutic Approaches
- (2016) Julia Beermann et al. PHYSIOLOGICAL REVIEWS
- Role of interleukin-6 in cancer progression and therapeutic resistance
- (2016) Neeraj Kumari et al. TUMOR BIOLOGY
- Effects of YM155 on survivin levels and viability in neuroblastoma cells with acquired drug resistance
- (2016) Yvonne Voges et al. Cell Death & Disease
- Diverse drug-resistance mechanisms can emerge from drug-tolerant cancer persister cells
- (2016) Michael Ramirez et al. Nature Communications
- Targeting P-glycoprotein function, p53 and energy metabolism: Combination of metformin and 2-deoxyglucose reverses the multidrug resistance of MCF-7/Dox cells to doxorubicin
- (2016) Chaojun Xue et al. Oncotarget
- Dietary phytochemicals and cancer chemoprevention: a review of the clinical evidence
- (2016) Ritesh Kotecha et al. Oncotarget
- The role of p53 in cancer drug resistance and targeted chemotherapy
- (2016) Karin Hientz et al. Oncotarget
- Cancer-associated fibroblasts treated with cisplatin facilitates chemoresistance of lung adenocarcinoma through IL-11/IL-11R/STAT3 signaling pathway
- (2016) Leilei Tao et al. Scientific Reports
- Overexpression of Mitochondria Mediator Gene TRIAP1 by miR-320b Loss Is Associated with Progression in Nasopharyngeal Carcinoma
- (2016) Yingqin Li et al. PLoS Genetics
- MDM2 Inhibition Sensitizes Prostate Cancer Cells to Androgen Ablation and Radiotherapy in a p53-Dependent Manner
- (2016) Felix Y. Feng et al. NEOPLASIA
- Targeting CD73 in the tumor microenvironment with MEDI9447
- (2016) Carl M. Hay et al. OncoImmunology
- Resveratrol elicits anti-colorectal cancer effect by activating miR-34c-KITLG in vitro and in vivo
- (2015) Shu Yang et al. BMC CANCER
- How Do Cytotoxic Lymphocytes Kill Cancer Cells?
- (2015) L. Martinez-Lostao et al. CLINICAL CANCER RESEARCH
- SOX2 Promotes the Epithelial to Mesenchymal Transition of Esophageal Squamous Cells by Modulating Slug Expression through the Activation of STAT3/HIF-α Signaling
- (2015) Hui Gao et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Cancer Microenvironment: What Can We Learn from the Stem Cell Niche
- (2015) Lukas Lacina et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Interleukin-6 expression by interactions between gynecologic cancer cells and human mesenchymal stem cells promotes epithelial-mesenchymal transition
- (2015) KYEONG A SO et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Akt inhibitors in cancer treatment: The long journey from drug discovery to clinical use (Review)
- (2015) GEORGE MIHAI NITULESCU et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Upregulation of PD-L1 by EGFR Activation Mediates the Immune Escape in EGFR-Driven NSCLC: Implication for Optional Immune Targeted Therapy for NSCLC Patients with EGFR Mutation
- (2015) Nan Chen et al. Journal of Thoracic Oncology
- HDAC inhibitors still need a home run, despite recent approval
- (2015) Malini Guha NATURE REVIEWS DRUG DISCOVERY
- p53 in survival, death and metabolic health: a lifeguard with a licence to kill
- (2015) Flore Kruiswijk et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Apoptosis inhibitor TRIAP1 is a novel effector of drug resistance
- (2015) CAROLINE ADAMS et al. ONCOLOGY REPORTS
- Comparison of 2D- and 3D-culture models as drug-testing platforms in breast cancer
- (2015) YOSHINORI IMAMURA et al. ONCOLOGY REPORTS
- ILs-3, 6 and 11 increase, but ILs-10 and 24 decrease stemness of human prostate cancer cells in vitro
- (2015) Dan-Dan Yu et al. Oncotarget
- Direct Interaction between Carcinoma Cells and Cancer Associated Fibroblasts for the Regulation of Cancer Invasion
- (2015) Hideki Yamaguchi et al. Cancers
- Cancer Associated Fibroblast-Derived Hepatocyte Growth Factor Inhibits the Paclitaxel-Induced Apoptosis of Lung Cancer A549 Cells by Up-Regulating the PI3K/Akt and GRP78 Signaling on a Microfluidic Platform
- (2015) Li Ying et al. PLoS One
- Expression of stemness genes in primary breast cancer tissues: the role of SOX2 as a prognostic marker for detection of early recurrence
- (2015) Mauro Finicelli et al. Oncotarget
- Epigallocatechin-3-Gallate Potentiates the Effect of Curcumin in Inducing Growth Inhibition and Apoptosis of Resistant Breast Cancer Cells
- (2014) Shengpeng Wang et al. AMERICAN JOURNAL OF CHINESE MEDICINE
- PKCδ/midkine pathway drives hypoxia-induced proliferation and differentiation of human lung epithelial cells
- (2014) Hanying Zhang et al. AMERICAN JOURNAL OF PHYSIOLOGY-CELL PHYSIOLOGY
- The Role of Mechanical Forces in Tumor Growth and Therapy
- (2014) Rakesh K. Jain et al. Annual Review of Biomedical Engineering
- d-alpha-tocopheryl polyethylene glycol succinate (TPGS) induces cell cycle arrest and apoptosis selectively in Survivin-overexpressing breast cancer cells
- (2014) Christiana M. Neophytou et al. BIOCHEMICAL PHARMACOLOGY
- Colon cancer: Cancer stem cells markers, drug resistance and treatment
- (2014) Zuzana Kozovska et al. BIOMEDICINE & PHARMACOTHERAPY
- Structurally diverse MDM2–p53 antagonists act as modulators of MDR-1 function in neuroblastoma
- (2014) L Chen et al. BRITISH JOURNAL OF CANCER
- Treatment of resistant metastatic melanoma using sequential epigenetic therapy (decitabine and panobinostat) combined with chemotherapy (temozolomide)
- (2014) Chang Xia et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- 5-Azacytidine enhances efficacy of multiple chemotherapy drugs in AML and lung cancer with modulation of CpG methylation
- (2014) MATHIAS FÜLLER et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Importance of carcinoma-associated fibroblast-derived proteins in clinical oncology
- (2014) Gabor Valcz et al. JOURNAL OF CLINICAL PATHOLOGY
- Drugging the p53 pathway: understanding the route to clinical efficacy
- (2014) Kian Hoe Khoo et al. NATURE REVIEWS DRUG DISCOVERY
- Self-consumption: the interplay of autophagy and apoptosis
- (2014) Guillermo Mariño et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
- Cost-Effectiveness Analysis of Hydralazine and Magnesium Valproate LP Associated With Treatment for Adult Patients with Metastatic Recurrent or Persistent Cervical Cancer in Mexico
- (2014) H. Soto et al. VALUE IN HEALTH
- Cancer-associated fibroblasts regulate the plasticity of lung cancer stemness via paracrine signalling
- (2014) Wan-Jiun Chen et al. Nature Communications
- Overcoming multiple drug resistance mechanisms in medulloblastoma
- (2014) Ramadhan T Othman et al. Acta Neuropathologica Communications
- Drug Resistance in Cancer: An Overview
- (2014) Genevieve Housman et al. Cancers
- Cancer-Associated Fibroblasts as Another Polarized Cell Type of the Tumor Microenvironment
- (2014) Martin Augsten Frontiers in Oncology
- Wogonin enhances antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand in vivo through ROS-mediated downregulation of cFLIPL and IAP proteins
- (2013) Lan Yang et al. APOPTOSIS
- Fibroblast-mediated drug resistance in cancer
- (2013) Kim H.T. Paraiso et al. BIOCHEMICAL PHARMACOLOGY
- Sox2 promotes tamoxifen resistance in breast cancer cells
- (2013) Marco Piva et al. EMBO Molecular Medicine
- Reprogramming cell death: BCL2 family inhibition in hematological malignancies
- (2013) Lydia Scarfò et al. IMMUNOLOGY LETTERS
- Methylation and histone deacetylase inhibition in combination with platinum treatment in patients with advanced malignancies
- (2013) Gerald S. Falchook et al. INVESTIGATIONAL NEW DRUGS
- Microenvironmental regulation of tumor progression and metastasis
- (2013) Daniela F Quail et al. NATURE MEDICINE
- Interleukin-6 Mediates Epithelial–Stromal Interactions and Promotes Gastric Tumorigenesis
- (2013) Hiroto Kinoshita et al. PLoS One
- Functional Investigation of NCI-H460-Inducible Myofibroblasts on the Chemoresistance to VP-16 with a Microfluidic 3D Co-Culture Device
- (2013) Yuanyuan Hao et al. PLoS One
- Difluorinated-Curcumin (CDF) Restores PTEN Expression in Colon Cancer Cells by Down-Regulating miR-21
- (2013) Sanchita Roy et al. PLoS One
- MicroRNA-30c inhibits human breast tumour chemotherapy resistance by regulating TWF1 and IL-11
- (2013) Jessica Bockhorn et al. Nature Communications
- Epigenetic mechanisms in tumorigenesis, tumor cell heterogeneity and drug resistance
- (2012) Roel H. Wilting et al. DRUG RESISTANCE UPDATES
- Targeting the Bcl-2 family for cancer therapy
- (2012) Shibu Thomas et al. EXPERT OPINION ON THERAPEUTIC TARGETS
- ERβ-Mediated Estradiol Enhances Epithelial Mesenchymal Transition of Lung Adenocarcinoma through Increasing Transcription of Midkine
- (2012) Guangfeng Zhao et al. MOLECULAR ENDOCRINOLOGY
- High survivin mRNA expression is a predictor of poor prognosis in breast cancer: a comparative study at the mRNA and protein level
- (2012) Chunsen Xu et al. Breast Cancer
- Akt, FoxO and regulation of apoptosis
- (2011) Xinbo Zhang et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- Midkine induces epithelial-mesenchymal transition through Notch2/Jak2-Stat3 signaling in human keratinocytes
- (2011) Yiping Huang et al. CELL CYCLE
- Stimulation of the midkine/ALK axis renders glioma cells resistant to cannabinoid antitumoral action
- (2011) M Lorente et al. CELL DEATH AND DIFFERENTIATION
- Synergistic Activity of Fenretinide and the Bcl-2 Family Protein Inhibitor ABT-737 against Human Neuroblastoma
- (2011) H. Fang et al. CLINICAL CANCER RESEARCH
- Apoptotic cell signaling in cancer progression and therapy
- (2011) Jessica Plati et al. Integrative Biology
- Luteolin induces apoptosis in multidrug resistant cancer cells without affecting the drug transporter function: Involvement of cell line-specific apoptotic mechanisms
- (2011) Prema S. Rao et al. INTERNATIONAL JOURNAL OF CANCER
- Novel Mechanism of Anti-apoptotic Function of 78-kDa Glucose-regulated Protein (GRP78)
- (2011) Hui Zhou et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Impacting tumor cell-fate by targeting the inhibitor of apoptosis protein survivin
- (2011) Ronan J Kelly et al. Molecular Cancer
- Combination Epigenetic Therapy Has Efficacy in Patients with Refractory Advanced Non-Small Cell Lung Cancer
- (2011) R. A. Juergens et al. Cancer Discovery
- Survivin and IAP proteins in cell-death mechanisms
- (2010) Dario C. Altieri BIOCHEMICAL JOURNAL
- The landscape of somatic copy-number alteration across human cancers
- (2010) Rameen Beroukhim et al. NATURE
- Wnt activity defines colon cancer stem cells and is regulated by the microenvironment
- (2010) Louis Vermeulen et al. NATURE CELL BIOLOGY
- Caspase activation pathways: some recent progress
- (2009) S P Cullen et al. CELL DEATH AND DIFFERENTIATION
- Hepatocyte Growth Factor Reduces Susceptibility to an Irreversible Epidermal Growth Factor Receptor Inhibitor in EGFR-T790M Mutant Lung Cancer
- (2009) T. Yamada et al. CLINICAL CANCER RESEARCH
- BH3-only proteins: The death-puppeteer's wires
- (2009) Fabio Ghiotto et al. CYTOMETRY PART A
- Life and death by death receptors
- (2009) Maria Eugenia Guicciardi et al. FASEB JOURNAL
- Curcumin sensitizes human colorectal cancer to capecitabine by modulation of cyclin D1, COX-2, MMP-9, VEGF and CXCR4 expression in an orthotopic mouse model
- (2009) Ajaikumar B. Kunnumakkara et al. INTERNATIONAL JOURNAL OF CANCER
- Human Caspases: Activation, Specificity, and Regulation
- (2009) Cristina Pop et al. JOURNAL OF BIOLOGICAL CHEMISTRY
- Cytoplasmic functions of the tumour suppressor p53
- (2009) Douglas R. Green et al. NATURE
- BH3-only proteins and their roles in programmed cell death
- (2009) M Giam et al. ONCOGENE
- The role of PAK-1 in activation of MAP kinase cascade and oncogenic transformation by Akt
- (2009) P R Somanath et al. ONCOGENE
- Resveratrol down-regulates survivin and induces apoptosis in human multidrug-resistant SPC-A-1/CDDP cells
- (2009) Zhao ONCOLOGY REPORTS
- Glucose-regulated protein 78: A new partner of p53 in trophoblast
- (2009) Serge Arnaudeau et al. PROTEOMICS
- Cancer-Associated Stromal Fibroblasts Promote Pancreatic Tumor Progression
- (2008) R. F. Hwang et al. CANCER RESEARCH
- mTOR inhibition reverses acquired endocrine therapy resistance of breast cancer cells at the cell proliferation and gene-expression levels
- (2008) Sandra E. Ghayad et al. CANCER SCIENCE
- Survivin: Key Regulator of Mitosis and Apoptosis and Novel Target for Cancer Therapeutics
- (2008) A. C. Mita et al. CLINICAL CANCER RESEARCH
- The PTEN/PI3K/AKT Signalling Pathway in Cancer, Therapeutic Implications
- (2008) Amancio Carnero et al. CURRENT CANCER DRUG TARGETS
- ROS and p53: A versatile partnership
- (2008) Bin Liu et al. FREE RADICAL BIOLOGY AND MEDICINE
- IAP-targeted therapies for cancer
- (2008) E C LaCasse et al. ONCOGENE
- Caspases in apoptosis and beyond
- (2008) J Li et al. ONCOGENE
- Akt2 overexpression plays a critical role in the establishment of colorectal cancer metastasis
- (2008) P. G. Rychahou et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas
- (2008) K. D. Mason et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Over-expressed and truncated midkines promote proliferation of BGC823 cells in vitro and tumor growth in vivo
- (2008) Qing-Ling Wang et al. WORLD JOURNAL OF GASTROENTEROLOGY
- The BCL-2 protein family: opposing activities that mediate cell death
- (2007) Richard J. Youle et al. NATURE REVIEWS MOLECULAR CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started